CHARLES LANDERS: Open Payments
NPI 1285988576 · ANDOVER, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 36 payments from 12 companies in 2025. Trend: 2023 $749 · 2024 $541 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $188 |
| Amgen Inc. | 10 | $136 |
| Novo Nordisk Inc | 5 | $86 |
| Lilly USA, LLC | 4 | $67 |
| Astellas Pharma US Inc | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| PFIZER INC. | 2 | $29 |
| SANOFI PASTEUR INC. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: BREZTRI, OTEZLA, Wegovy, Veozah, CAPLYTA, FARXIGA, JARDIANCE, EVENITY.
Industry payments across KS — which companies pay providers there.
